GoHealth, Inc. (GOCO)
| Market Cap | 9.17M -86.0% |
| Revenue (ttm) | 152.79M -81.7% |
| Net Income | -293.88M |
| EPS | -20.41 |
| Shares Out | 29.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,788,792 |
| Open | 0.2988 |
| Previous Close | 0.2887 |
| Day's Range | 0.2900 - 0.3430 |
| 52-Week Range | 0.2871 - 7.1160 |
| Beta | 1.17 |
| Analysts | Buy |
| Price Target | 5.13 (+1,538.98%) |
| Earnings Date | May 18, 2026 |
About GOCO
GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company offers Medicare plans, including Medicare advantage, Medicare supplement, prescription drug plans, and special needs plans. It also operates a technology platform that leverages machine-learning algorithms of insurance purchasing behavior to reimagine the process of matching a health plan for a consumer’s specific needs. In addition, the company offers partner marketing services. It sells its products through i... [Read more]
Financial Performance
In 2025, GoHealth's revenue was $361.85 million, a decrease of -54.71% compared to the previous year's $798.89 million. Losses were -$261.05 million, 3861.9% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for GOCO stock is "Buy." The 12-month stock price target is $5.13, which is an increase of 1,538.98% from the latest price.
News
GoHealth Files for Bankruptcy, Handing Control to Lenders
The insurance brokerage, once valued at $6.6 billion, entered chapter 11 with nearly $1 billion in debt and a plan that leaves operations intact.
GoHealth, subsidiaries voluntarily file chapter 11 petitions
GoHealth (GOCO) announced that GoHealth and certain of its subsidiaries have voluntarily filed chapter 11 petitions with the United States Bankruptcy Court for the District of Delaware to implement th...
GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders
Initiates voluntary prepackaged Chapter 11 process to implement Restructuring Transactions that have the support of 100% of its lenders, over 60% of the holders of GoHealth, Inc. Class A Common Stock,...
GoHealth Quarterly report: Q1 2026
GoHealth has published its Q1 2026 quarterly earnings report on May 18, 2026.
GoHealth Proxy statement: Proxy filing
GoHealth filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
GoHealth Proxy statement: Proxy filing
GoHealth filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
Stonegate Capital Partners Updates Coverage on GoHealth Inc. (GOCO) 4Q25
Dallas, Texas--(Newsfile Corp. - April 16, 2026) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners Updates Coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth's 4Q25 results continued to refle...
GoHealth, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises GoHealth , Inc. , (“ GoHealth " or the "Company") ( NASDAQ : GOCO) investors that the firm has initiated an investigation ...
GoHealth downgraded to Hold from Buy at Freedom Broker
Freedom Broker downgraded GoHealth (GOCO) to Hold from Buy with a price target of $1.50, down from $4.50. The company’s Q4 revenue dropped 97% year-over-year amid deterioration in Medicare Advantage…
GoHealth Annual report: Q4 2025
GoHealth has published its Q4 2025 annual report on March 31, 2026.
GoHealth files to sell 9.57M shares of Class A common stock for holders
17:05 EST GoHealth (GOCO) files to sell 9.57M shares of Class A common stock for holders
GoHealth Registration statement: Registration Filing
GoHealth filed a registration statement on December 16, 2025, providing details about a securities offering with the SEC.
GoHealth price target lowered to $5 from $12 at RBC Capital
RBC Capital lowered the firm’s price target on GoHealth (GOCO) to $5 from $12 and keeps a Sector Perform rating on the shares. The firm is updating its model following…
GoHealth Registration statement: Registration Filing
GoHealth filed a registration statement on November 26, 2025, providing details about a securities offering with the SEC.
William Blair downgrades GoHealth, says market headwinds likely to persist
William Blair downgraded GoHealth (GOCO) to Market Perform from Outperform. Q3 revenue and Medicare submissions were below the firm’s expectations as the company pulled back on new enrollment growth, ...
GoHealth downgraded to Market Perform from Outperform at William Blair
William Blair downgraded GoHealth (GOCO) to Market Perform from Outperform.
GoHealth files to sell 4.77M shares of Class A common stock for holders
16:14 EST GoHealth (GOCO) files to sell 4.77M shares of Class A common stock for holders
Stonegate Capital Partners Updates Coverage on GoHealth Inc. (GOCO) 2025 Q3
Dallas, Texas--(Newsfile Corp. - November 17, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. reported a difficu...
GoHealth Registration statement: Registration Filing
GoHealth filed a registration statement on November 17, 2025, providing details about a securities offering with the SEC.
GoHealth price target lowered to $10 from $20 at Noble Capital
Noble Capital analyst Patrick McCann lowered the firm’s price target on GoHealth (GOCO) to $10 from $20 and keeps an Outperform rating on the shares. Q3 results came in below…
GoHealth Earnings Call Transcript: Q3 2025
Retention, quality, and cash preservation were prioritized over MA volume growth amid tightening health plan economics. Liquidity remains strong with $32M cash and $40M in new financing, supporting technology investment and potential industry consolidation.
GoHealth Quarterly report: Q3 2025
GoHealth has published its Q3 2025 quarterly earnings report on November 13, 2025.
GoHealth Earnings release: Q3 2025
GoHealth released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.
GoHealth Slides: Q3 2025
GoHealth has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 13, 2025.
GoHealth reports Q3 EPS ($11.80) vs. 46c last year
Reports Q3 revenue $34.2M vs. $118.3M last year. The company said, “The Company navigated a materially different Medicare Advantage environment by intentionally reducing Medicare Advantage volume, con...